Indoco Remedies · NSE: INDOCO · BSE: 532612
Q2 FY20 results · Jul–Sep 2019
Indoco Remedies reported revenue from operations of ₹292.57 crore and net profit of ₹7.81 crore for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 292.57 | — | — | — | — |
| Other income | 0.58 | — | — | — | — |
| Total income | 293.15 | — | — | — | — |
| Profit before tax | 9.80 | — | — | — | — |
| Net profit for the period | 7.81 | — | — | — | — |
| EPS, basic (₹) | 0.85 | — | — | — | — |
| Net margin (%) | 2.7 | — | — |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 291.97 | 235.63 | +23.9% | 252.67 | +15.6% |
| Other income | 0.58 | 0.33 | +75.8% | 0.64 | −9.4% |
| Total income | 292.55 | 235.96 | +24.0% | 253.31 | +15.5% |
| Profit before tax | 9.31 | (10.52) | Turned profit | 0.28 | 33x |
| Net profit for the period | 7.33 | (7.79) | Turned profit | 2.18 | +236.2% |
| EPS, basic (₹) | 0.80 | (0.85) | Turned profit | 0.24 | +233.3% |
| Net margin (%) | 2.5 | -3.3 | 0.9 |
Consolidated
- Filed with BSE
- 31 Oct 2019, 17:54 IST
- Board meeting
- 30 Oct 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 Oct 2019, 17:54 IST
- Board meeting
- 30 Oct 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE